Literature DB >> 25673014

The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients.

Beatriz Tavira1, Juan Gómez1, Carmen Díaz-Corte2, Diego Coronel3, Carlos Lopez-Larrea4, Beatriz Suarez5, Eliecer Coto6.   

Abstract

The ABCB1 gene encodes the P-glycoprotein (P-gp) that drives the transmembrane efflux of many drugs. The donor ABCB1 polymorphisms have been related with chronic histological damage and long-term renal function among kidney transplanted patients who received cyclosporine A and tacrolimus (Tac). The aim of our study was to determine whether the donor ABCB1 3435 C/T genotype was related with renal function among Tac-treated renal transplanted patients. Kidney donors (n=65) and recipients (n=90) were genotyped for the ABCB1 rs1045642 (c.3435 C/T) and CYP3A5 rs776746 single-nucleotide polymorphisms. The estimated glomerular filtration rate (eGFR) was calculated with the modification of diet in renal disease formulae at five post-transplant times (2 weeks and 1, 3, 6 and 12 months). The recipient ABCB1 and CYP3A5 genotypes had no significant effect on the eGFR at all the post-transplant times. We found significantly lower eGFR values among patients who received a kidney from ABCB1 3435 T carriers (P<0.01). In conclusion, our study confirmed the potential impact of the donor ABCB1 3435 genotype on the post-transplant renal function among patients treated with Tac.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25673014     DOI: 10.1038/jhg.2015.12

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  23 in total

1.  Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians.

Authors:  Iain A M Macphee; Salim Fredericks; Maha Mohamed; Michelle Moreton; Nicholas D Carter; Atholl Johnston; Lawrence Goldberg; David W Holt
Journal:  Transplantation       Date:  2005-02-27       Impact factor: 4.939

Review 2.  Chronic renal allograft rejection: pathophysiologic considerations.

Authors:  Simone A Joosten; Yvo W J Sijpkens; Cees van Kooten; Leendert C Paul
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

3.  Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro.

Authors:  Yang Dai; Mary F Hebert; Nina Isoherranen; Connie L Davis; Christopher Marsh; Danny D Shen; Kenneth E Thummel
Journal:  Drug Metab Dispos       Date:  2006-02-24       Impact factor: 3.922

4.  Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients.

Authors:  Norihiko Tsuchiya; Shigeru Satoh; Hitoshi Tada; Zhenhua Li; Chikara Ohyama; Kazunari Sato; Toshio Suzuki; Tomonori Habuchi; Tetsuro Kato
Journal:  Transplantation       Date:  2004-10-27       Impact factor: 4.939

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients.

Authors:  Beatriz Tavira; Eliecer Coto; Carmen Diaz-Corte; Victoria Alvarez; Carlos López-Larrea; Francisco Ortega
Journal:  Pharmacogenet Genomics       Date:  2013-08       Impact factor: 2.089

7.  Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

Authors:  Eric Thervet; Dany Anglicheau; Barry King; Marie-Hélène Schlageter; Bruno Cassinat; Philippe Beaune; Christophe Legendre; Ann K Daly
Journal:  Transplantation       Date:  2003-10-27       Impact factor: 4.939

8.  Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients.

Authors:  Séverine Crettol; Jean-Pierre Venetz; Massimiliano Fontana; John-David Aubert; Nicolas Ansermot; Marc Fathi; Manuel Pascual; Chin B Eap
Journal:  Pharmacogenet Genomics       Date:  2008-04       Impact factor: 2.089

9.  Donor age and ABCB1 1199G>A genetic polymorphism are independent factors affecting long-term renal function after kidney transplantation.

Authors:  Martine De Meyer; Vincent Haufroid; Laure Elens; Fabio Fusaro; Damiano Patrono; Luc De Pauw; Nada Kanaan; Eric Goffin; Michel Mourad
Journal:  J Surg Res       Date:  2012-07-20       Impact factor: 2.192

10.  Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

Authors:  Dany Anglicheau; Céline Verstuyft; Pierre Laurent-Puig; Laurent Becquemont; Marie-Hélène Schlageter; Bruno Cassinat; Philippe Beaune; Christophe Legendre; Eric Thervet
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

View more
  5 in total

1.  Effect of CYP3A5 and ABCB1 polymorphisms on the interaction between tacrolimus and itraconazole in patients with connective tissue disease.

Authors:  Masaru Togashi; Takenori Niioka; Atsushi Komatsuda; Mizuho Nara; Shin Okuyama; Ayumi Omokawa; Maiko Abumiya; Hideki Wakui; Naoto Takahashi; Masatomo Miura
Journal:  Eur J Clin Pharmacol       Date:  2015-07-17       Impact factor: 2.953

Review 2.  Pharmacogenetics of Membrane Transporters of Tacrolimus in Solid Organ Transplantation.

Authors:  Camille Tron; Florian Lemaitre; Céline Verstuyft; Antoine Petitcollin; Marie-Clémence Verdier; Eric Bellissant
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

Review 3.  The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Authors:  Samira S Farouk; Joshua L Rein
Journal:  Adv Chronic Kidney Dis       Date:  2020-01       Impact factor: 3.620

Review 4.  Donor-Recipient Non-HLA Variants, Mismatches and Renal Allograft Outcomes: Evolving Paradigms.

Authors:  Priyanka Jethwani; Arundati Rao; Laurine Bow; Madhav C Menon
Journal:  Front Immunol       Date:  2022-04-01       Impact factor: 8.786

5.  Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant Recipients.

Authors:  Karola Warzyszyńska; Michał Zawistowski; Edyta Karpeta; Agnieszka Jałbrzykowska; Maciej Kosieradzki
Journal:  Ann Transplant       Date:  2022-07-26       Impact factor: 1.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.